Baxter Ventures is set to exit the kidney dialysis device maker, which has just filed to go public following upwards of $430m in venture funding.
US-based dialysis technology producer Outset Medical has filed for a $100m initial public offering that would give medical device maker Baxter International the chance to exit.
Outset is working on a system that can perform kidney dialysis using only a tap and an electrical outlet. It incorporates water purification system technology in addition to the automated production of dialysis fluid.
The company received US regulatory approval for home use of its product in March this year and intends to…
